Abiopharma

🔍 Scheinman Daniel (Director)

Company: Zoom Communications, Inc. (ZM)

Report Date: 2026-06-10

Detailed Transactions and Holdings:

• Acquired 3,583 shares of Class A Common Stock (Direct)
  Date: 2026-06-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 13,913.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,583 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-10 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F3
• Acquired 3,012 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,012.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
• Holds 80,000 shares of Director Stock Option (right to buy) at $10.79 per share (Derivative)
  Date: 2026-06-10 | Code: H | Expires: 2028-11-29 | shares_owned_after: 80,000.00 | Footnotes: F4, F5
• Holds 1,126,281 shares of Class B Common Stock (Derivative)
  Date: 2026-06-10 | Code: H | shares_owned_after: 1,126,281.00 | Footnotes: F5, F5, F5, F6
• Holds 437,974 shares of Class B Common Stock (Derivative)
  Date: 2026-06-10 | Code: H | shares_owned_after: 437,974.00 | Footnotes: F5, F5, F5, F1

Footnotes:

• F1: The shares are held of record by Dan & Zoe Scheinman Trust Dated 2/23/01, for which the Reporting Person serves as trustee.
• F2: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer's Class A Common Stock.
• F3: The reporting person received an award of restricted stock units, 100% of which will vest on the first anniversary date of the grant (or, if sooner, the day immediately preceding the next annual meeting that occurs following the grant date).
• F4: 1/48 of the shares subject to the option vests in equal monthly installments commencing one month from November 29, 2018. The shares subject to this option are early exercisable, subject to the Issuer's right to repurchase.
• F5: Each share of Class B Common Stock is convertible at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon (a) other than Eric S. Yuan, the death of the Reporting Person, or (b) any transfer by the Reporting Person except certain "Permitted Transfers" described in the Issuer's certificate of incorporation. All outstanding shares of Class B Common Stock will convert into shares of Class A Common Stock upon the earliest of (i) six months following the death or incapacity of Mr. Yuan, (ii) six months following the date that Mr. Yuan ceases providing services to the Issuer, (iii) the date specified by the holders of a majority of the shares of Class B Common Stock, and (iv) the 15-year anniversary of the closing of the Issuer's initial public offering.
• F6: The shares are held of record by The 2017 Scheinman Irrevocable Trust ("2017 Scheinman Trust"). The trustee for 2017 Scheinman Trust is Neuberger Berman Trust Company of Delaware N.A. The Reporting Person's family members are beneficiaries under the 2017 Scheinman Trust.